Paper35222007
Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway.
Long L and 11 others. Front Pharmacol, 2021. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway. Papers, record 35222007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35222007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26122615 | p53 in survival, death and metabolic health: a lifeguard with a licence to kill. | Nat Rev Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26122615 | PubMed |
| 2 | 33746585 | Qingda granule exerts neuroprotective effects against ischemia/reperfusion-induced cerebral injury via lncRNA GAS5/miR-137 signaling pathway. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33746585 | PubMed |
| 3 | 34084130 | Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34084130 | PubMed |
| 4 | 11316852 | Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. | J Am Soc Nephrol | 2001 | https://conductscience.org/library/papers/11316852 | PubMed |
| 5 | 32559624 | Qingda granules attenuate hypertensive cardiac remodeling and inflammation in spontaneously hypertensive rats. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/32559624 | PubMed |
| 6 | 16914423 | Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats. | Am J Physiol Regul Integr Comp Physiol | 2006 | https://conductscience.org/library/papers/16914423 | PubMed |
| 7 | 29441112 | Qingxuan Jiangya Decoction Mitigates Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating Transforming Growth Factor-β1/Smad Signaling Pathway. | Evid Based Complement Alternat Med | 2017 | https://conductscience.org/library/papers/29441112 | PubMed |
| 8 | 32475313 | NOX4/H2O2/mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury. | Hypertension | 2020 | https://conductscience.org/library/papers/32475313 | PubMed |
| 9 | 27455221 | Qingxuan Jiangya Decoction Reverses Vascular Remodeling by Inducing Vascular Smooth Muscle Cell Apoptosis in Spontaneously Hypertensive Rats. | Molecules | 2016 | https://conductscience.org/library/papers/27455221 | PubMed |
| 10 | 30340829 | Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/30340829 | PubMed |
| 11 | 30598687 | JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-κB Signaling-Mediated Microinflammation. | Evid Based Complement Alternat Med | 2018 | https://conductscience.org/library/papers/30598687 | PubMed |
| 12 | 28431922 | Microvascular injury and the kidney in hypertension. | Hipertens Riesgo Vasc | 2018 | https://conductscience.org/library/papers/28431922 | PubMed |
| 13 | 32199989 | Qingda granule inhibits angiotensin Ⅱ induced VSMCs proliferation through MAPK and PI3K/AKT pathways. | J Ethnopharmacol | 2020 | https://conductscience.org/library/papers/32199989 | PubMed |
| 14 | 27038419 | Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis. | Atherosclerosis | 2016 | https://conductscience.org/library/papers/27038419 | PubMed |
| 15 | 29293543 | Angiopoietin-1 deficiency increases renal capillary rarefaction and tubulointerstitial fibrosis in mice. | PLoS One | 2018 | https://conductscience.org/library/papers/29293543 | PubMed |
| 16 | 31923435 | The NEW-HOPE study and emerging therapies for difficult-to-control and resistant hypertension. | Prog Cardiovasc Dis | 2020 | https://conductscience.org/library/papers/31923435 | PubMed |
| 17 | 16339963 | Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. | Am J Physiol Renal Physiol | 2006 | https://conductscience.org/library/papers/16339963 | PubMed |
| 18 | 24925726 | Regulated cell death in AKI. | J Am Soc Nephrol | 2014 | https://conductscience.org/library/papers/24925726 | PubMed |
| 19 | 33537809 | Mechanism of herbal medicine on hypertensive nephropathy (Review). | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33537809 | PubMed |
| 20 | 26655953 | Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26655953 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41416166 | [Mechanism of Trifolin in Attenuating Hypertension-Induced Renal Cell Apoptosis via Modulation of the MAPK Signaling Pathway]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/41416166 | PubMed |
| 40520190 | Trifolin inhibits the calcium-driven contraction pathway in vascular smooth muscle. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40520190 | PubMed |
| 40341164 | Effects and mechanisms of trifolin on attenuating hypertension-induced vascular smooth muscle cell proliferation and collagen deposition in vivo and in vitro. | Sci Rep | 2025 | https://conductscience.org/library/papers/40341164 | PubMed |
| 39525316 | GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling Pathway. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39525316 | PubMed |
| 39338362 | Gastrodin Alleviates Angiotensin II-Induced Hypertension and Myocardial Apoptosis via Inhibition of the PRDX2/p53 Pathway In Vivo and In Vitro. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39338362 | PubMed |
| 39271481 | The phytochemical plumbagin: mechanism behind its "pleiotropic" nature and potential as an anticancer treatment. | Arch Toxicol | 2024 | https://conductscience.org/library/papers/39271481 | PubMed |
| 37701045 | Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats. | Drug Des Devel Ther | 2023 | https://conductscience.org/library/papers/37701045 | PubMed |
| 37211627 | Gastrodin attenuates angiotensin II-induced vascular contraction and MLCK/p-MLC2 pathway activation. | Pharm Biol | 2023 | https://conductscience.org/library/papers/37211627 | PubMed |
| 36642814 | Dietary choline intake is necessary to prevent systems-wide organ pathology and reduce Alzheimer's disease hallmarks. | Aging Cell | 2023 | https://conductscience.org/library/papers/36642814 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35222007
GET https://conductscience.org/api/papers/v1/35222007/references?page=2